Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1

The antitumorigenic mechanism of the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib is still a matter of debate. Using lung cancer cell lines (A549, H460) and metastatic cells derived from a lung cancer patient, the present study investigates the impact of celecoxib on the expression of inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Schellhorn, Melina, Haustein, Maria, Frank, Marcus, Linnebacher, Michael, Hinz, Burkhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770776/
https://www.ncbi.nlm.nih.gov/pubmed/26513172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770776/
https://www.ncbi.nlm.nih.gov/pubmed/26513172

Ejemplares similares